LAURIE KEATING - 09 Jun 2021 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
EVP, Chief Legal Officer
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Laurie Keating
Issuer symbol
ALNY
Transactions as of
09 Jun 2021
Transactions value $
-$267,036
Form type
4
Filing time
11 Jun 2021, 16:13:48 UTC
Next filing
14 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Sale -$267,036 -1,734 -25% $154 5,132 09 Jun 2021 Direct F1
holding ALNY Common Stock 434 09 Jun 2021 by Managed Account F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.
F2 Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.